An experimental new treatment is showing early promise in the fight against liver fibrosis – a serious and often silent ...

Liver disease is a modifiable cardiac risk factor, and this study confirmed that it can be quantified with MRI iron corrected ...

Roche is rolling out a new diagnostic test to help assess hidden liver fibrosis in patients showing signs of metabolic ...

It's a key component of weight lost and diabetes drugs and researchers have found it can do wonders for those who have ...

To advance the understanding and treatment of liver disease by pursuing innovative, transformative basic and translational ...

Roche has introduced the Elecsys PRO-C3 test for evaluating the liver fibrosis severity in individuals with signs of ...

An experimental new treatment is showing early promise in the fight against liver fibrosis - a serious and often silent condition that affects around ...

VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company”) announced today that its world-leading NAMkind™ platform for liver toxicology prediction, provided as a commercial ...

Results from the Phase III MYR301 trial show that 36% of patients who achieved undetectable hepatitis delta virus levels when ...

A STUDENT from Jersey is carrying out a new project to better understand and find new ways to treat a chronic liver disease as part of her PhD studies. Former Hautlieu student Millie-Rose Doolan is ...

Roche launches innovative Elecsys PRO-C3 test to improve precision in evaluating liver fibrosis severity: Basel Wednesday, May 7, 2025, 10:00 Hrs [IST] Roche announced the launch ...

Cholesterol tests check the components of fat in your blood and compare them to normal ranges. Your clinician might also use ...